IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure

Clinical trial NCT00242788 · COMPLETED

Trial details

NCT number: NCT00242788
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2004-02-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.